|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/10 | |
| C12N 15/09 | |||
| C12P 21/02 | |||
| C07K 14/75 | |||
| C07K 14/81 |
| (11) | Number of the document | 3088513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14873182.1 |
| Date of filing the European patent application | 2014-12-26 | |
| (97) | Date of publication of the European application | 2016-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2014/084516 |
| Date | 2014-12-26 |
| (87) | Number | WO 2015/099124 |
| Date | 2015-07-02 |
| (30) | Number | Date | Country code |
| 2013273145 | 2013-12-27 | JP |
| (72) |
UNO, Shusei, JP
OTAKI, Momoko, JP
MURAKAMI, Kouji, JP
IDENO, Shoji, JP
|
| (73) |
Japan Blood Products Organization,
4-1 Hamamatsucho 2-chome Minato-ku, Tokyo 105-6107,
JP
|
| (54) | RECOMBINANT FIBRINOGEN HIGH-PRODUCTION LINE AND METHOD FOR PRODUCING SAME |
| RECOMBINANT FIBRINOGEN HIGH-PRODUCTION LINE AND METHOD FOR PRODUCING SAME |